AMENDMENT NO. 2 to ASSIGNMENT AGREEMENTAssignment Agreement • May 12th, 2009 • Pharmacyclics Inc • Pharmaceutical preparations
This AMENDMENT TO ASSIGNMENT AGREEMENT ("Amendment"), effective as of March 2, 2009 (the "Amendment Date"), is made and entered into by and between PHARMACYCLICS, INC., a Delaware corporation having a place of business at 995 East Arques Avenue, Sunnyvale, California 94085, ("Pharmacyclics") and CELERA CORPORATION having a place of business at 1401 Harbor Bay Parkway, Alameda, California 94502 ("Celera"). Pharmacyclics and Celera may each be referred to herein individually as a "Party" or, collectively, as "Parties."
AMENDMENT NO. 3 to ASSIGNMENT AGREEMENTAssignment Agreement • May 12th, 2009 • Pharmacyclics Inc • Pharmaceutical preparations
This AMENDMENT TO ASSIGNMENT AGREEMENT ("Amendment"), effective as of March 30, 2009 (the "Amendment Date"), is made and entered into by and between PHARMACYCLICS, INC., a Delaware corporation having a place of business at 995 East Arques Avenue, Sunnyvale, California 94085, ("Pharmacyclics") and CELERA CORPORATION having a place of business at 1401 Harbor Bay Parkway, Alameda, California 94502 ("Celera"). Pharmacyclics and Celera may each be referred to herein individually as a "Party" or, collectively, as "Parties."
STOCK PURCHASE AGREEMENT by and among Pharmacyclics, Inc., as Issuer and Company and the other parties named herein, as Purchasers February 18, 2009Stock Purchase Agreement • May 12th, 2009 • Pharmacyclics Inc • Pharmaceutical preparations • New York
STOCK PURCHASE AGREEMENT (the "Agreement") dated as of February 18, 2009, by and among Pharmacyclics, Inc., a Delaware corporation (the "Company"), and each of the other persons listed on Schedule 1 hereto (each is individually referred to as a "Purchaser" and collectively, the "Purchasers").
AMENDMENT NO.1 TO LOAN AGREEMENTLoan Agreement • May 12th, 2009 • Pharmacyclics Inc • Pharmaceutical preparations • New York
AMENDMENT NO. 1 to LOAN AGREEMENT entered into as of March 31, 2009 (this "Amendment") by and between Pharmacyclics, Inc., a Delaware corporation having a principal place of business at 995 E. Arques Avenue, Sunnyvale, CA 94085-4521 (the "Company"), and Robert W. Duggan & Associates (the "Lender")
